Selected research
Market Analysis & Forecast
Global Nimodipine Market Analysis and Forecast 2026-2032
Market perspective
The global Nimodipine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Nimodipine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Nimodipine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Nimodipine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Nimodipine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Nimodipine include Yangtze River Pharmaceutical, Shandong Xinhua Pharmaceutical, Sichuan Kelun Pharmaceutical, Hubei Jumpcan Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Cisen Pharmaceutical, Bayer, Bionpharma and Azurity, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Nimodipine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Nimodipine, also provides the sales of main regions and countries. Of the upcoming market potential for Nimodipine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nimodipine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nimodipine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nimodipine sales, projected growth trends, production technology, application and end-user industry.
Nimodipine Segment by Company
Yangtze River Pharmaceutical
Shandong Xinhua Pharmaceutical
Sichuan Kelun Pharmaceutical
Hubei Jumpcan Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
Cisen Pharmaceutical
Bayer
Bionpharma
Azurity
Avet Pharmaceuticals Inc.
Nimodipine Segment by Type
Solution
Tablets
Capsule
Nimodipine Segment by Application
Clinics
Hospital
Pharmacy
Others
Nimodipine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nimodipine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nimodipine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nimodipine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Nimodipine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Nimodipine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nimodipine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Solution
- Tablets
- Capsule
Applications
- Clinics
- Hospital
- Pharmacy
- Others
Companies covered
- Yangtze River Pharmaceutical
- Shandong Xinhua Pharmaceutical
- Sichuan Kelun Pharmaceutical
- Hubei Jumpcan Pharmaceutical
- Jiangsu Hengrui Pharmaceuticals
- Cisen Pharmaceutical
- Bayer
- Bionpharma
- Azurity
- Avet Pharmaceuticals Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Nimodipine Market by Type
- 1.2.1 Global Nimodipine Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Solution
- 1.2.3 Tablets
- 1.2.4 Capsule
- 1.3 Nimodipine Market by Application
- 1.3.1 Global Nimodipine Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Clinics
- 1.3.3 Hospital
- 1.3.4 Pharmacy
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Nimodipine Market Dynamics
- 2.1 Nimodipine Industry Trends
- 2.2 Nimodipine Industry Drivers
- 2.3 Nimodipine Industry Opportunities and Challenges
- 2.4 Nimodipine Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Nimodipine Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Nimodipine Revenue by Region
- 3.2.1 Global Nimodipine Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Nimodipine Revenue by Region (2021-2026)
- 3.2.3 Global Nimodipine Revenue by Region (2027-2032)
- 3.2.4 Global Nimodipine Revenue Market Share by Region (2021-2032)
- 3.3 Global Nimodipine Sales Estimates and Forecasts 2021-2032
- 3.4 Global Nimodipine Sales by Region
- 3.4.1 Global Nimodipine Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Nimodipine Sales by Region (2021-2026)
- 3.4.3 Global Nimodipine Sales by Region (2027-2032)
- 3.4.4 Global Nimodipine Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Nimodipine Revenue by Manufacturers
- 4.1.1 Global Nimodipine Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Nimodipine Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Nimodipine Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Nimodipine Sales by Manufacturers
- 4.2.1 Global Nimodipine Sales by Manufacturers (2021-2026)
- 4.2.2 Global Nimodipine Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Nimodipine Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Nimodipine Sales Price by Manufacturers (2021-2026)
- 4.4 Global Nimodipine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Nimodipine Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Nimodipine Manufacturers, Product Type & Application
- 4.7 Global Nimodipine Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Nimodipine Market CR5 and HHI
- 4.8.2 2025 Nimodipine Tier 1, Tier 2, and Tier 3
5 Nimodipine Market by Type
- 5.1 Global Nimodipine Revenue by Type
- 5.1.1 Global Nimodipine Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Nimodipine Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Nimodipine Revenue Market Share by Type (2021-2032)
- 5.2 Global Nimodipine Sales by Type
- 5.2.1 Global Nimodipine Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Nimodipine Sales by Type (2021-2032) & (tons)
- 5.2.3 Global Nimodipine Sales Market Share by Type (2021-2032)
- 5.3 Global Nimodipine Price by Type
6 Nimodipine Market by Application
- 6.1 Global Nimodipine Revenue by Application
- 6.1.1 Global Nimodipine Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Nimodipine Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Nimodipine Revenue Market Share by Application (2021-2032)
- 6.2 Global Nimodipine Sales by Application
- 6.2.1 Global Nimodipine Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Nimodipine Sales by Application (2021-2032) & (tons)
- 6.2.3 Global Nimodipine Sales Market Share by Application (2021-2032)
- 6.3 Global Nimodipine Price by Application
7 Company Profiles
- 7.1 Yangtze River Pharmaceutical
- 7.1.1 Yangtze River Pharmaceutical Company Information
- 7.1.2 Yangtze River Pharmaceutical Business Overview
- 7.1.3 Yangtze River Pharmaceutical Nimodipine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Yangtze River Pharmaceutical Nimodipine Product Portfolio
- 7.1.5 Yangtze River Pharmaceutical Recent Developments
- 7.2 Shandong Xinhua Pharmaceutical
- 7.2.1 Shandong Xinhua Pharmaceutical Company Information
- 7.2.2 Shandong Xinhua Pharmaceutical Business Overview
- 7.2.3 Shandong Xinhua Pharmaceutical Nimodipine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Shandong Xinhua Pharmaceutical Nimodipine Product Portfolio
- 7.2.5 Shandong Xinhua Pharmaceutical Recent Developments
- 7.3 Sichuan Kelun Pharmaceutical
- 7.3.1 Sichuan Kelun Pharmaceutical Company Information
- 7.3.2 Sichuan Kelun Pharmaceutical Business Overview
- 7.3.3 Sichuan Kelun Pharmaceutical Nimodipine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Sichuan Kelun Pharmaceutical Nimodipine Product Portfolio
- 7.3.5 Sichuan Kelun Pharmaceutical Recent Developments
- 7.4 Hubei Jumpcan Pharmaceutical
- 7.4.1 Hubei Jumpcan Pharmaceutical Company Information
- 7.4.2 Hubei Jumpcan Pharmaceutical Business Overview
- 7.4.3 Hubei Jumpcan Pharmaceutical Nimodipine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Hubei Jumpcan Pharmaceutical Nimodipine Product Portfolio
- 7.4.5 Hubei Jumpcan Pharmaceutical Recent Developments
- 7.5 Jiangsu Hengrui Pharmaceuticals
- 7.5.1 Jiangsu Hengrui Pharmaceuticals Company Information
- 7.5.2 Jiangsu Hengrui Pharmaceuticals Business Overview
- 7.5.3 Jiangsu Hengrui Pharmaceuticals Nimodipine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Jiangsu Hengrui Pharmaceuticals Nimodipine Product Portfolio
- 7.5.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
- 7.6 Cisen Pharmaceutical
- 7.6.1 Cisen Pharmaceutical Company Information
- 7.6.2 Cisen Pharmaceutical Business Overview
- 7.6.3 Cisen Pharmaceutical Nimodipine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Cisen Pharmaceutical Nimodipine Product Portfolio
- 7.6.5 Cisen Pharmaceutical Recent Developments
- 7.7 Bayer
- 7.7.1 Bayer Company Information
- 7.7.2 Bayer Business Overview
- 7.7.3 Bayer Nimodipine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Bayer Nimodipine Product Portfolio
- 7.7.5 Bayer Recent Developments
- 7.8 Bionpharma
- 7.8.1 Bionpharma Company Information
- 7.8.2 Bionpharma Business Overview
- 7.8.3 Bionpharma Nimodipine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Bionpharma Nimodipine Product Portfolio
- 7.8.5 Bionpharma Recent Developments
- 7.9 Azurity
- 7.9.1 Azurity Company Information
- 7.9.2 Azurity Business Overview
- 7.9.3 Azurity Nimodipine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Azurity Nimodipine Product Portfolio
- 7.9.5 Azurity Recent Developments
- 7.10 Avet Pharmaceuticals Inc.
- 7.10.1 Avet Pharmaceuticals Inc. Company Information
- 7.10.2 Avet Pharmaceuticals Inc. Business Overview
- 7.10.3 Avet Pharmaceuticals Inc. Nimodipine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Avet Pharmaceuticals Inc. Nimodipine Product Portfolio
- 7.10.5 Avet Pharmaceuticals Inc. Recent Developments
8 North America
- 8.1 North America Nimodipine Market Size by Type
- 8.1.1 North America Nimodipine Revenue by Type (2021-2032)
- 8.1.2 North America Nimodipine Sales by Type (2021-2032)
- 8.1.3 North America Nimodipine Price by Type (2021-2032)
- 8.2 North America Nimodipine Market Size by Application
- 8.2.1 North America Nimodipine Revenue by Application (2021-2032)
- 8.2.2 North America Nimodipine Sales by Application (2021-2032)
- 8.2.3 North America Nimodipine Price by Application (2021-2032)
- 8.3 North America Nimodipine Market Size by Country
- 8.3.1 North America Nimodipine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Nimodipine Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Nimodipine Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Nimodipine Market Size by Type
- 9.1.1 Europe Nimodipine Revenue by Type (2021-2032)
- 9.1.2 Europe Nimodipine Sales by Type (2021-2032)
- 9.1.3 Europe Nimodipine Price by Type (2021-2032)
- 9.2 Europe Nimodipine Market Size by Application
- 9.2.1 Europe Nimodipine Revenue by Application (2021-2032)
- 9.2.2 Europe Nimodipine Sales by Application (2021-2032)
- 9.2.3 Europe Nimodipine Price by Application (2021-2032)
- 9.3 Europe Nimodipine Market Size by Country
- 9.3.1 Europe Nimodipine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Nimodipine Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Nimodipine Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Nimodipine Market Size by Type
- 10.1.1 China Nimodipine Revenue by Type (2021-2032)
- 10.1.2 China Nimodipine Sales by Type (2021-2032)
- 10.1.3 China Nimodipine Price by Type (2021-2032)
- 10.2 China Nimodipine Market Size by Application
- 10.2.1 China Nimodipine Revenue by Application (2021-2032)
- 10.2.2 China Nimodipine Sales by Application (2021-2032)
- 10.2.3 China Nimodipine Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Nimodipine Market Size by Type
- 11.1.1 Asia Nimodipine Revenue by Type (2021-2032)
- 11.1.2 Asia Nimodipine Sales by Type (2021-2032)
- 11.1.3 Asia Nimodipine Price by Type (2021-2032)
- 11.2 Asia Nimodipine Market Size by Application
- 11.2.1 Asia Nimodipine Revenue by Application (2021-2032)
- 11.2.2 Asia Nimodipine Sales by Application (2021-2032)
- 11.2.3 Asia Nimodipine Price by Application (2021-2032)
- 11.3 Asia Nimodipine Market Size by Country
- 11.3.1 Asia Nimodipine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Nimodipine Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Nimodipine Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Nimodipine Market Size by Type
- 12.1.1 SAMEA Nimodipine Revenue by Type (2021-2032)
- 12.1.2 SAMEA Nimodipine Sales by Type (2021-2032)
- 12.1.3 SAMEA Nimodipine Price by Type (2021-2032)
- 12.2 SAMEA Nimodipine Market Size by Application
- 12.2.1 SAMEA Nimodipine Revenue by Application (2021-2032)
- 12.2.2 SAMEA Nimodipine Sales by Application (2021-2032)
- 12.2.3 SAMEA Nimodipine Price by Application (2021-2032)
- 12.3 SAMEA Nimodipine Market Size by Country
- 12.3.1 SAMEA Nimodipine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Nimodipine Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Nimodipine Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Nimodipine Value Chain Analysis
- 13.1.1 Nimodipine Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Nimodipine Production Mode & Process
- 13.2 Nimodipine Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Nimodipine Distributors
- 13.2.3 Nimodipine Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst